Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
- Weitere Titel
-
Identifikation von neuen Antagonisten gegen Zielstrukturen in Kontext von Entzündung und Juckreiz in der Haut
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.26083/tuprints-00023314
- URN
-
urn:nbn:de:tuda-tuprints-233141
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jäger, Anita
- Kolmar, Harald
- Hagen, Jörg von
- Universitäts- und Landesbibliothek
Entstanden
- 2024
Ähnliche Objekte (12)
Target-Site Penetration of Active Ingredients in Human Skin
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Target-Site Penetration of Active Ingredients in Human Skin
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Target-Site Penetration of Active Ingredients in Human Skin
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy